About Our Sponsors

Arivan Research (AVR) is a specialized consulting firm that works closely with biopharmaceutical, diagnostic and medical device clients to augment BD&L activities. Essentially, our expertise involves conducting in-depth primary research with KOLs, clinical investigators, healthcare company personnel, payers, and other industry sources to address important BD-related questions and issues. A thorough analysis of secondary and/or audit data may be completed as well. From there, our highly-experienced group of MBAs, MDs & PharmDs analyzes the information to provide rational and insightful recommendations. In fact, the combination of exhaustive primary research methodologies, secondary data interpretation and in-depth analysis by industry professionals distinguishes AVR from many other consulting firms. Among other assignments, AVR has successfully completed proprietary engagements to: identify and validate in-licensing candidates; analyze co-promotion opportunities; assess acquisition targets; evaluate new market opportunities (including white space evaluations); investigate new technologies; and elicit payer perceptions on new products and services. AVR maintains strong capabilities across many disease categories -- including but not limited to oncology, cardiology, endocrinology, infectious disease, immunology, pain, neurology, psychiatry, and gastroenterology. AVR's ultimate goal: provide critical information and compelling insights to ensure our clients' success in the marketplace.

Deloitte Recap LLC (member of Deloitte Touche Tohmatsu Limited) provides products, consulting and advisory services focusing on Biopharma alliance deals and clinical development. The Recap IQ database products provide critical information on alliances and clinical developments within the industry. Deloitte Recap has a database of over 35,000 pharma/biopharma deals including many with unredacted contracts to use as a reference for business development professionals structuring their own deals. Deloitte Recap’s customers include pharma, biotech, government agencies, academia, law firms, private financing companies and financial services companies.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in the U.S., Europe, and Asia, we work with leading corporations and innovators to protect, advocate, and leverage their most important IP assets. We handle all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation, with particular expertise in Abbreviated New Drug Application (ANDA) and biotechnology cases.

Finnegan is a recognized leader in safeguarding biotechnology and pharmaceutical IP. Our biotechnology/pharmaceutical practice group includes 89 professionals, 53 of which hold advanced degrees and have substantial research experience. In addition, 34 members of the group held industry positions prior to joining Finnegan, and five are former patent examiners. For more information, please visit www.finnegan.com.

IntraLinks® provides enterprise-class solutions which facilitate the secure, compliant and auditable exchange of critical information, collaboration and workflow management inside and outside the enterprise. Our on-demand solutions help you organize, manage, share and track information, enabling you to accelerate your workflow, optimize your business processes and realize new profit potential. Since 1997, IntraLinks has been used on critical business processes by more than 750,000 users from 90,000 organizations worldwide, including 10 of the top 10 pharmaceutical companies and hundreds of biotechs. IntraLinks counts 800 of the Fortune 1000 as clients, including enterprises such as AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank and the FDIC. For more information, visit www.intralinks.com.